The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Behçet Disease and their association with thrombosis
Articles > Article · 2010
Authors: Ayhan DÖNMEZ, Kenan AKSU, Hakan AYDIN, Gökhan KESER, Seckin CAGIRGAN, EKER DOĞANAVŞARGİL, Murat TOMBULOĞLU
Thrombosis Research, Journal Indexed in SCI Expanded, International, WoS, 2010, vol 126, pp 207-210
DOI: 10.1016/j.thromres.2010.05.019
Summary
Objective: To investigate the plasma levels of activated thrombin activatable fibrinolysis inhibitor (aTAFI) and thrombomodulin (TM) in Behcet disease (BD) and their relationship with thrombosis.